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Studies have demonstrated that lipoteichoic acid (LTA) is involved in the
immunomodulatory properties of some immunobiotic lactobacilli. The aim of this
work was to evaluate whether LTA contributes to the capacity of Lactobacillus
plantarum CRL1506 in modulating the intestinal innate antiviral immune response.
A D-alanyl-lipoteichoic acid biosynthesis protein (dltD) knockout CRL1506 strain
(L. plantarum1dltD) was obtained, and its ability to modulate Toll-like receptor (TLR)-
3-mediated immune response was evaluated in vitro in porcine intestinal epithelial (PIE)
cells and in vivo in Balb/c mice. Wild-type (WT) CRL1506 (L. plantarum WT) was used as
positive control. The challenge of PIE cells with the TLR3 agonist poly(I:C) significantly
increased interferon (IFN)-β, interleukin (IL)-6, and monocyte chemoattractant protein
(MCP)-1 expressions. PIE cells pretreated with L. plantarum1dltD or L. plantarum WT
showed higher levels of IFN-β while only L. plantarum WT significantly reduced the
expression of IL-6 and MCP-1 when compared with poly(I:C)-treated control cells. The
oral administration of L. plantarum WT to mice prior the intraperitoneal injection of
poly(I:C) significantly increased IFN-β and IL-10 and reduced intraepithelial lymphocytes
(CD3+NK1.1+CD8αα+) and pro-inflammatory mediators (TNF-α, IL-6, and IL-15) in the
intestinal mucosa. Similar to the WT strain, L. plantarum1dltD-treated mice showed
enhanced levels of IFN-β after poly(I:C) challenge. However, treatment of mice with
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L. plantarum1dltD was not able to increase IL-10 or reduce CD3+NK1.1+CD8αα+
cells, TNF-α, IL-6, or IL-15 in the intestine. These results indicate that LTA would be
a key molecule in the anti-inflammatory effect induced by the CRL1506 strain in the
context of TLR3-mediated inflammation.
Keywords: immunobiotic, D-alanyl-lipoteichoic acid biosynthesis protein mutant, Lactobacillus plantarum
CRL1506, intestinal immunity, lipoteichoic acid
INTRODUCTION
One of the fundamental problems of the world related to
nutrition is the immunosuppression associated with malnutrition
(1, 2). Undernutrition is one of the factors that contribute most
to the global burden of disease, with increasing numbers affecting
the most vulnerable populations in developing countries (2).
More than a third of child deaths worldwide are attributed to
malnutrition and its profound impact on the host resistance
to infections. In this regard, diarrhea remains the leading
cause of death of children, particularly in those with severe
malnutrition (3). Although in recent years it has been possible
to reduce infant mortality and morbidity resulting from
rotavirus gastroenteritis, such infection is still a persistent
problem worldwide and is one of the most common causes
of hospitalization and mortality in children. Globally, at least
200,000 children under 5 years of age die of diarrhea every year
due to the severe dehydration and electrolyte disorders caused by
rotavirus infection (4). The majority of rotavirus-related deaths
(>80%) are found in low-income countries, where there is a
high prevalence of child malnutrition and limited access to
medical care (5).
The World Health Organization has proposed a cohesive
approach to end preventable diarrhea deaths in children
(3). The plan proposes interventions to create healthy
environments, promotes practices to protect children from
infectious diseases, and ensures that all children have access
to appropriate preventive and treatment measures. The
document emphasizes the importance of healthy food and
vaccination for the prevention of intestinal infections in
children. In this regard, various clinical trials and animal
model studies have demonstrated the ability of probiotic
lactic acid bacteria (LAB) with immunomodulatory activities,
also known as immunobiotics, to improve the resistance to
intestinal viral infections (6–8). Although great advances have
been made in the use of immunobiotics for the development
of immunomodulatory functional foods or as adjuvants in
experimental mucosal vaccines (6–8), deeper studies are still
necessary to achieve a better understanding of their interaction
with the immune system. Deeper knowledge of the cellular
and molecular interactions of immunobiotics with host
immune and non-immune cells could help in the selection
of the most efficient strains and lay the scientific basis for
their safe use, in particular in high-risk populations such as
malnourished children.
Previous in vitro transcriptomic studies showed that
Lactobacillus plantarum CRL1506 is able to modulate the
expression of type I interferons (IFNs), antiviral factors,
cytokines, chemokines, and adhesion molecules in porcine
intestinal epithelial (PIE) cells challenged with the Toll-like
receptor (TLR)-3 ligand poly(I:C) (9). In addition, studies in
porcine antigen-presenting cells isolated from Peyer’s patches
demonstrated that the CRL1506 strain differentially modulated
the expression of IFN-γ, interleukin (IL)-1β, IL-12, IL-6, and
tumor necrosis factor (TNF)-α (10). Moreover, L. plantarum
CRL1506 was able to activate porcine CD172a+CD11R1high
dendritic cells (DCs) and CD172a+CD11R1− macrophages
as demonstrated by the enhanced levels of the major
histocompatibility complex (MHC)-II and co-stimulatory
molecules CD80/86 (10). The patterns of IFNs, cytokines, and
chemokines induced by L. plantarum CRL1506 in resident
intestinal immune and non-immune cells allow us to predict
an improved recruitment and activation of immune cells to the
gut mucosa, which could beneficially influence the elimination
of the virus. On the other hand, taking into consideration
that the deregulated activation of immune cells and/or their
excessive recruitment into the infected tissue could contribute
to the local cellular damage in the context of viral infection,
we also evaluated the ability of L. plantarum CRL1506 to
protect against the TLR3-mediated intestinal inflammatory
alterations. Our in vivo studies in mice demonstrated that
orally administered CRL1506 strain, prior to the intraperitoneal
challenge of animals with poly(I:C), significantly reduced the
severity of intestinal damage triggered by TLR3 activation.
The beneficial effect of the immunobiotic strain was related
to its capacity of modulating the expression of IL-15 and
retinoic acid early inducible-1 (RAE1) in epithelial cells and the
activation of CD3+NK1.1+CD8αα+ intraepithelial lymphocytes
(IELs) (11).
In order to gain deeper knowledge of the bacterial molecules
involved in the beneficial effects of L. plantarum CRL1506,
in this work, we aimed to evaluate whether lipoteichoic acid
(LTA) contributes to the capacity of the immunobiotic strain of
modulating the intestinal innate antiviral immune response. A D-
alanyl-lipoteichoic acid biosynthesis protein (dltD) knockout
CRL1506 strain (L. plantarum1dltD) was obtained, and its ability
to modulate TLR3-mediated immune response was evaluated
in vitro and in vivo. Similar to the wild-type (WT) strain, the
mutant L. plantarum1dltD was able to differentially modulate
IFN-γ and IFN-β in response to poly(I:C) challenge in vitro
and in vivo. However, L. plantarum1dltD was not able to
increase IL-10 or reduce the inflammatory damage mediated by
CD3+NK1.1+CD8αα+ cells and IL-15 in the intestinal mucosa.
The results of this work indicate that LTA would be a key
molecule in the anti-inflammatory effect induced by L. plantarum
CRL1506 in the context of TLR3-mediated inflammation.
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MATERIALS AND METHODS
Microorganisms
Lactobacillus plantarum CRL1506 was obtained from the
Reference Centre for Lactobacilli (CERELA CONICET)
Culture Collection (Tucuman, Argentina). Cultures
were kept freeze-dried and then rehydrated using the
following medium: tryptone, 10.0 g; meat extract, 5.0 g;
peptone, 15.0 g; and distilled water, 1 L, pH 7. Bacteria
were cultured for 12 h at 37◦C (final log phase) in
Man–Rogosa–Sharpe broth (MRS, Oxoid, Cambridge,
United Kingdom).
The mutant D-alanyl-lipoteichoic acid biosynthesis protein
knockout L. plantarum CRL1506 strain (L. plantarum 1dltD)
was obtained according to the method described by Yamauchi
et al. (12). Briefly, the dltD gene was obtained by PCR using
primers No. 65 and No. 66 (Table 1 and Figure 1). By
using this gene fragment as a template, the 27-bp in-frame
deletion of dltD was obtained by PCR using primers No.67
and No. 98, followed by primers No. 99 and No. 100. These
fragments were combined by overlap PCR using No. 67
and No. 100 (Table 1 and Figure 1). This fragment was
digested by SacI and KpnI and then inserted into pSG+E2
(thermo-sensitive replicon) that was obtained from the Food
Research and Development Center, Meiji Dairies Corporation
(Tokyo, Japan), by DNA Ligation Kit Ver1 (Takara Bio Inc.,
Japan) to generate the pSG+dD plasmid. The construction
of this vector was performed in Lactococcus lactis IL1403
(kindly given by the Food Research and Development
Center, Meiji Dairies Corporation, Tokyo, Japan). The
pSG+dD was electroporated into L. plantarum CRL1506
according to the method described by De Keersmaecker et al.
(13). A double crossover event was performed according
to the method described by Biswas et al. (14) in order
to obtain a 1dltD L. plantarum CRL1506 strain. The
27-bp deletion in the dltD gene of CRL1506 mutant was
confirmed by sequencing.
Scanning electron microscope (SEM) was used to analyze the
bacterial surfaces of WT L. plantarum CRL1506 (L. plantarum
WT) and L. plantarum 1dltD. For this purpose, the bacteria were
cultured for 16 h at 37◦C in MRS broth and then centrifuged
(6,000 × g for 5 min at 5◦C), and the pellets were diluted
10-fold with phosphate buffered saline (PBS). Samples were
dropped into membrane filter polycarbonate of 0.2 µm× 13 mm
TABLE 1 | Sequence of the primers used in this study.
Primer number Sequence
No. 65 GGACGTTAACCTGTTTGATGAAGGA
No. 66 CCATCCTTTGCTTGATAGTGTAACTCTAC
No. 67 ACACGGTACCGGGTTCCGTCCAACTTTTATTGGAA
No. 98 CATCATCCAGCGCCTCGTTGGCTGACAAGG
No. 99 CCTTGTCAGCCAACGAGGCGCTGGATGATG
No. 100 CACAGAGCTCGCCCGCAATTCCAAAACGTG
No. 129 GATGCATTGGATCAAATCGTG
(ADVANTEC), and the bacterial cells were placed on the filter
using suction filtration. These filters were allowed to stand in 2%
glutaraldehyde for 1 h at room temperature to fix the cells. The
samples were observed by SEM.
Western blot analysis and high-performance liquid
chromatography (HPLC) were performed to analyze LTA
in L. plantarum WT and L. plantarum 1dltD. The collection of
cell walls was performed according to the method described by
Hirose et al. (15). The overnight cultures of WT and 1dltD in
MRS medium were added to fresh MRS medium and cultured at
37◦C for 5 h (middle of log phase). The cultures were centrifuged
at 6,000 × g for 5 min. PBS wash was performed twice, and
the pellets were resuspended by PBS. Then, bacterial cells were
disrupted by Micro SmashTM MS-100R (Tomy Seiko Co., Ltd.,
Japan) (4,500 rpm for 3 min on ice). The recovered liquid was
centrifuged at 5,000 rpm for 20 min at 4◦C, and the supernatant
was centrifuged again at 40,000 rpm for 20 min at 4◦C. These
pellets were freeze dried. For Western blot analysis, anti-LTA
antibody (Ab), Mouse Lipoteichoic Acid Monoclonal Antibody
(GeneTex, Inc., United States) was used as primary Ab (1:500)
for 16 h at 4◦C and Alkaline Phosphatase AffiniPure Goat Anti-
Mouse IgG (H + L) (Jackson ImmunoResearch Laboratories,
Inc., United States) was used as secondary Ab (1:20,000) for 1 h
at room temperature. The ECF reaction was performed for 5 min
by using ECF Substrate for Western blotting (GE HealthCare,
Inc., United States). For HPLC, acid hydrolysis of the samples
was performed by the method described Hirose et al. (15). The
samples were diluted in 6N hydrochloric acid (HCl) at 100◦C
for 15 h and were neutralized, added to equal volume of 75%
(vol/vol) EtOH. These samples were loaded to HPLC in order
to measure the concentration of alanine, glutamic acid, and
diaminopimelic acid.
Porcine Intestinal Epithelial Cells
The PIE cell line was originally derived from intestinal epithelia
isolated from an unsuckled neonatal swine (16). PIE cells
are intestinal non-transformed cultured cells that assume a
monolayer with a cobblestone and epithelial-like morphology
and with close contact between cells during culture (16–18). PIE
cells were maintained in Dulbecco’s modified Eagle’s medium
(DMEM) (Invitrogen Corporation, Carlsbad, CA) supplemented
with 10% fetal calf serum (FCS), 100 mg/mL streptomycin and
100 U/mL penicillin at 37◦C in an atmosphere of 5% CO2
(9, 10, 18, 19).
Immunomodulatory Effect of Lactobacilli
in Porcine Intestinal Epithelial Cells
The study of the immunomodulatory capacity of L. plantarum
WT and L. plantarum 1dltD was performed in PIE cells as
described previously (9, 10). PIE cells were seeded at 3 × 104
cells per well in 12-well type I collagen-coated plates (Sumitomo
Bakelite Co., Tokyo, Japan) and cultured for 3 days. After
changing medium, lactobacilli (5× 108 cells/ml) were added, and
48 h later, each well was washed vigorously with medium at least
three times to eliminate all stimulants. Then, cells were stimulated
with poly(I:C) (60 µg/ml) for 12 h for RT-PCR studies.
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FIGURE 1 | Development of a D-alanyl-lipoteichoic acid biosynthesis protein (dltD) mutant from Lactobacillus plantarum CRL1506. (A) Summary of the strategy
used for the development of L. plantarum 1dltD by double-crossover. Primer sequences are listed in Table 1. (B) Confirmation of the deletion of 27 bp in the dltD
gene by PCR analysis. (C) Growth curve and (D) electron microscope analysis of wild-type (WT) and 1dltD mutant from Lactobacillus rhamnosus CRL1506.
Quantitative Expression Analysis by
Two-Step Real-Time Quantitative PCR
Two-step real-time quantitative PCR (qPCR) was performed
to characterize the expression of selected genes in PIE cells
as described previously (9). TRIzol reagent (Invitrogen) was
used for total RNA isolation from each PIE cell sample, and
Quantitect reverse transcription (RT) kit (Qiagen, Tokyo, Japan)
was used for the synthesis of all cDNAs according to the
manufacturer’s recommendations. qPCR was carried out using
a 7300 real-time PCR system (Applied Biosystems, Warrington,
United Kingdom) and the Platinum SYBR green qPCR SuperMix
uracil-DNA glycosylase (UDG) with 6-carboxyl-X-rhodamine
(ROX) (Invitrogen). The primers used in this study were
described before (9, 10, 20). The PCR cycling conditions were
2 min at 50◦C, followed by 2 min at 95◦C, and then 40 cycles
of 15 s at 95◦C, 30 s at 60◦C, and 30 s at 72◦C. The reaction
mixtures contained 5 µl of sample cDNA and 15 µl of master mix,
which included the sense and antisense primers. According to the
minimum information for publication of quantitative real-time
PCR experiments guidelines, β-actin was used as a housekeeping
gene because of its high stability across porcine various tissues
(17, 20, 21). Expression of β-actin was used to normalize cDNA
levels for differences in total cDNA levels in the samples.
Animals, Feeding Procedures, and
Poly(I:C) Challenge
Male 6-week-old BALB/c mice were obtained from the closed
colony kept at CERELA-CONICET (Tucuman, Argentina).
Animals were housed in individual plastic cages in a controlled
atmosphere (22◦C± 2◦C temperature, 55%± 2% humidity) with
a 12-h light/dark cycle. L. plantarum WT and L. plantarum 1dltD
were orally administered to different groups of mice for five
consecutive days at a dose of 108 cells/mouse/day in a controlled
volume of the drinking water supplemented with non-fat milk
(10%) to ensure the complete consumption of the viable bacteria
(22, 23). The treated groups and the untreated control mice were
fed a conventional balanced diet ad libitum. Mice were challenged
by the intraperitoneal route with 100 µl of PBS containing 30 µg
poly(I:C) according to our previous publication (11). Biochemical
markers of injury as well as intestinal cytokine concentrations
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were evaluated 2 days after poly(I:C) administration as described
below. All experiments were carried out in compliance with the
Guide for Care and Use of Laboratory Animals and approved by
the Ethical Committee of Animal Care at CERELA, Argentina
(protocol number BIOT-CRL/14) (11).
Biochemical Markers of Injury
Lactate dehydrogenase (LDH) and aspartate aminotransferase
(AST) activities were determined in the serum to evaluate general
toxicity of poly(I:C) in mice challenged by the intraperitoneal
injection. Blood samples were obtained through cardiac puncture
under anesthesia. LDH and AST activities, expressed as units per
liter of serum, were determined by measuring the formation of
the reduced form of nicotinamide adenine dinucleotide (NAD)
using the Wiener reagents and procedures (Wiener Lab, Buenos
Aires, Argentina) (11).
Cytokine Concentrations
Serum samples were obtained as described before. Intestinal fluid
samples were obtained according to our previous publication
(11). Briefly, the small intestine was flushed with 5 ml of PBS and
the fluid was centrifuged (10,000? × g, 4◦C 10?min) to separate
particulate material. The supernatant was kept frozen until use.
Tumor necrosis factor (TNF)-α, IL-6, IL-10, IL-15,
IFN-β, and IFN-γ concentrations in serum and intestinal
fluid samples were measured with commercially available
enzyme-linked immunosorbent assay (ELISA) technique kits
following the manufacturer’s recommendations (R&D Systems,
MN, United States).
Total and Differential Blood Leukocyte
Counts
The total number of leukocytes was determined with a
hemocytometer. Differential cell counts were performed by
counting 200 cells in blood smears stained with May Grünwald
Giemsa stain using a light microscope (1,000×), and absolute cell
numbers were calculated (24).
Intestinal Intraepithelial Lymphocytes
Intraepithelial lymphocytes were isolated according to our
previous publication (11). Briefly, Peyer’s patches were excised;
the small intestine was opened longitudinally and cut into 5-
mm-long pieces. Samples were washed twice in PBS containing
150 µg/ml streptomycin and 120 U/ml penicillin. The pieces
were then stirred at 37◦C in prewarmed RPMI 1640 containing
150 µg/ml streptomycin, 120 U/ml penicillin, and 5% FCS for
30 min, followed by vigorous shaking for 40 s. This process
was repeated, and the supernatants were passed through a
small cotton-glass wool column to remove cell debris and
were then separated on a Percoll density gradient (Amersham
Biosciences). A discontinuous density gradient (40% and 70%)
was used. The cells that layered between the 40% and 70%
fractions were collected as IELs. These IELs contained >90%
CD3+ cells, as determined by fluorescence-activated cell sorting
(FACS) analysis.
Cellular phenotypes in IEL populations were analyzed
by flow cytometry using fluorescein isothiocyanate (FITC)-
conjugated anti-CD3 and phycoerythrin (PE)-conjugated anti-
NK1.1 (PK136) and anti-CD8α (CTCD8b) (R&D Systems). Anti-
NKG2D (CX5) was purchased from eBioscience (San Diego,
CA, United States). To prevent non-specific binding, respective
isotype Abs were used as controls. Images of labeled cells
were acquired on a BD FACSCaliburTM flow cytometer (BD
Biosciences) and analyzed with FlowJo software (TreeStar).
Statistical Analysis
Experiments were performed in triplicate, and results were
expressed as mean ± standard deviation (SD). After verification
of the normal distribution of data, two-way ANOVA was used.
Tukey’s test (for pairwise comparisons of the means) was used
to test for differences between the groups. Differences were
considered significant at P < 0.05 or P < 0.01.
RESULTS
Development of L. plantarum 1dltD
Lactobacillus plantarum 1dltD was produced by double-
crossover (Figure 1A), and the deletion of 27-bp in the dltD
gene was confirmed by PCR analysis (Figure 1B) and sequencing
(data not shown). It has been reported that LTA mutations
in lactobacilli can lead to modifications on growth, cell wall
organization, cell morphology, or cell division. The 1dltD
mutant from Lactobacillus rhamnosus GG had defects in septum
formation and an increased cell length (25), while the 1dltD
mutant from L. plantarum WCFS1 showed increased autolysis,
defects in cell separation, and enhanced cell length (26). Then,
the ability of the mutant strain L. plantarum 1dltD to grow in
MRS medium as well as its surface and shape characteristics were
evaluated by comparing it with the WT L. plantarum CRL1506.
As shown in Figures 1C,D, the deletion of 27 bp in the dltD
gene did not affect the ability of L. plantarum 1dltD to grow
neither altered its shape or surface characteristics when compared
to L. plantarum WT. Those results are in line with the findings
of (27) that showed that the 1dltD mutant from L. acidophilus
NCFM had no growth or morphological defects.
In addition, LTA in WT and 1dltD strains was analyzed by
Western blot and HPLC. A reduction in LTA content (Figure 2A)
as well as a decrease in the Ala/Glu ratio (Figure 2B) were found
in L. plantarum 1dltD when compared with the WT strain.
Effect of L. plantarum1dltD in Toll-Like
Receptor 3-Challenged Porcine
Intestinal Epithelial Cells
In order to evaluate whether the alteration of the LTA
in L. plantarum CRL1506 induced modifications on its
immunomodulatory activities, we first studied in vitro its ability
to functionally modulate immune factor expression in PIE cells
after the activation of TLR3. For this purpose, PIE cells were
treated with L. plantarum1dltD or L. plantarum WT and then
challenged with the TLR3 agonist poly(I:C). The expressions of
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FIGURE 2 | Development of a D-alanyl-lipoteichoic acid biosynthesis protein (dltD) mutant from Lactobacillus plantarum CRL1506. Analysis of lipoteichoic acid (LTA)
by (A) Western blot and (B) high-performance liquid chromatography (HPLC) (Ala/Glu ratio) in wild-type (WT) and 1dltD mutant from Lactobacillus rhamnosus
CRL1506.
IFN-β, IL-6, and CCL2 were evaluated by qPCR (Figure 3). As it
was described previously (9, 10), the treatment of PIE cells with
L. plantarum WT significantly increased the expression of IFN-
β, while a decrease in the mRNA levels of IL-6 and CCL2 was
observed. No differences between 1dltD and WT strains were
found when the expression of IFN-β was compared. However,
the expression of both IL-6 and CCL2 were significantly higher
in 1dltD-treated PIE cells when compared to those stimulated
with L. plantarum WT (Figure 3).
Effect of L. plantarum1dltD in Toll-Like
Receptor 3-Induced Inflammatory
Damage in Mice
Taking into consideration that the in vitro studies suggested
that the alteration of LTA in L. plantarum CRL1506 would
also alter its anti-inflammatory properties, we next aimed to
evaluate whether L. plantarum1dltD was able to modulate
the intestinal inflammatory response and protect against the
damage induced by TLR3 activation by using an in vivo model.
Then, different groups of mice were fed L. plantarum1dltD
or L. plantarum WT and then challenged with the TLR3
agonist poly(I:C) as described in Materials and Methods. We
evaluated body weight loss and the biochemical markers LDH
and AST in serum to study the general health status of mice
after poly(I:C) administration (Figure 4). As it was reported
previously (11), poly(I:C) challenge significantly decreased the
body weight gain and increased the levels of serum LDH and
AST. Mice treated with L. plantarum WT showed reduced levels
of injury biochemical markers and improved body weight gain
when compared to control mice (Figure 4). On the other hand,
mice treated with L. plantarum1dltD showed levels of serum
LDH that were not different from those observed in the control
group. In addition, the mutant strain was able to reduce the
alteration of body weight gain and the levels of serum AST, but
its effect was significantly lower when compared to L. plantarum
WT (Figure 4).
Total and differential blood leukocyte counts were also
evaluated to study the systemic inflammatory response.
Challenge with poly(I:C) significantly increased the number of
leukocytes and neutrophils in blood. However, the numbers
of neutrophils were lower in L. plantarum WT-treated mice
when compared to the L. plantarum1dltD and control
groups (Figure 5).
Effect of L. plantarum1dltD on the
Innate Immune Response Induced by
Toll-Like Receptor 3
The intraperitoneal administration of poly(I:C) significantly
increased the levels of pro-inflammatory cytokines in
the intestine (Figure 6) and serum (Figure 7). Both
L. plantarum1dltD and L. plantarum WT were able to
improve the production of the antiviral factors IFN-β and
IFN-γ in the intestine and serum when compared to control
mice and with no differences between lactobacilli. As reported
previously (11), L. plantarum WT significantly reduced the
concentrations of TNF-α, IL-6, and IL-15 in intestinal fluid
(Figure 6) and serum (Figure 7). L. plantarum1dltD was as
effective as the WT strain to diminish the concentrations of
serum TNF-α (Figure 7). In addition, L. plantarum1dltD
was able to reduce the levels of intestinal IL-15, but it
was not efficient as the WT strain (Figure 6). The levels
of intestinal TNF-α and IL-6 (Figure 6) as well as serum
IL-6 and IL-15 (Figure 7) in 1dltD-treated mice were not
different from controls.
Only L. plantarum WT treatment was able to significantly
increase the levels of intestinal and serum IL-10, while the
concentrations of this regulatory cytokine in L. plantarum1dltD-
treated mice were not different from controls (Figures 6, 7).
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FIGURE 3 | Effect of a D-alanyl-lipoteichoic acid biosynthesis protein (dltD) mutant from Lactobacillus plantarum CRL1506 on innate antiviral immune response
triggered by Toll-like receptor 3 (TLR3) activation in porcine intestinal epithelial (PIE) cells. Expression of interferon (IFN)-β, interleukin (IL)-6, and monocyte
chemoattractant protein (MCP)-1/CCL2 genes in PIE cells treated with wild-type (WT) or 1dltD mutant from Lactobacillus rhamnosus CRL1506 and challenged with
the viral molecular associated pattern poly(I:C). PIE cells with no lactobacilli treatment and stimulated with poly(I:C) were used as controls. The results represent data
from three independent experiments. Significant differences when compared to the control group: *P < 0.05, **P < 0.01. Significant differences when compared to
the indicated group: †P < 0.05, ††P < 0.01.
FIGURE 4 | Effect of a D-alanyl-lipoteichoic acid biosynthesis protein (dltD) mutant from Lactobacillus plantarum CRL1506 on the inflammatory damage induced by
Toll-like receptor 3 (TLR3) activation in mice intestine. Body weight loss and serum biochemical markers lactate dehydrogenase (LDH) and aspartate
aminotransferase (AST) in mice orally treated with wild-type (WT) or 1dltD mutant from L. rhamnosus CRL1506 and challenged with an intraperitoneal injection of the
viral molecular associated pattern poly(I:C). Mice with no lactobacilli treatment and challenged with poly(I:C) were used as controls. The results represent data from
three independent experiments. Significant differences when compared to the control group: *P < 0.05, **P < 0.01. Significant differences when compared to the
indicated group: †P < 0.05.
FIGURE 5 | Effect of a D-alanyl-lipoteichoic acid biosynthesis protein (dltD) mutant from Lactobacillus plantarum CRL1506 on the inflammatory response induced by
Toll-like receptor 3 (TLR3) activation in mice intestine. Blood leukocyte and neutrophil counts in mice orally treated with wild-type (WT) or 1dltD mutant from
Lactobacillus rhamnosus CRL1506 and challenged with an intraperitoneal injection of the viral molecular associated pattern poly(I:C). Mice with no lactobacilli
treatment and challenged with poly(I:C) were used as controls. The results represent data from three independent experiments. Significant differences when
compared to the control group: *P < 0.05.
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FIGURE 6 | Effect of a D-alanyl-lipoteichoic acid biosynthesis protein (dltD) mutant from Lactobacillus plantarum CRL1506 on the innate antiviral immune response
triggered by Toll-like receptor 3 (TLR3) activation in mice intestine. Levels of intestinal interferon (IFN)-β, IFN-γ, interleukin (IL)-10, tumor necrosis factor (TNF)-α, IL-6,
and IL-15 in mice orally treated with wild-type (WT) or 1dltD mutant from Lactobacillus rhamnosus CRL1506 and challenged with an intraperitoneal injection of the
viral molecular associated pattern poly(I:C). Mice with no lactobacilli treatment and challenged with poly(I:C) were used as controls. The results represent data from
three independent experiments. Significant differences when compared to the control group: *P < 0.05, **P < 0.01. Significant differences when compared to the
indicated group: †P < 0.05.
Finally, we assessed the changes in the populations of intestinal
IELs in mice challenged with the TLR3 agonist poly(I:C).
For this purpose, we studied variations in CD3+NK1.1+ and
CD3+CD8αα+ populations as well as NKG2D expression within
IELs by flow cytometry. Poly(I:C) administration induced an
increase in all these three parameters evaluated (Figure 8).
L. plantarum WT-treated mice showed significantly decreased
numbers of intestinal CD3+NK1.1+ and CD3+CD8αα+ cells
and NKG2D expression when compared to controls. On the
contrary, the treatment of mice with L. plantarum1dltD was not
able to reduce the numbers of CD3+CD8αα+ cells (Figure 8).
The 1dltD strain reduced the numbers of CD3+NK1.1+
cells and the expression of NKG2D, but those parameters
were significantly higher than those observed in WT-treated
mice (Figure 8). We also evaluated the expression of the
NKG2D ligand RAE1 by qPCR. TLR3 activation increased
the expression of RAE1 in all the experimental groups
(Figure 8). Both L. plantarum1dltD and L. plantarum WT
were able to reduce RAE1 expression in the intestinal tissue
of mice; however, the levels of expression in WT-treated mice
were significantly lower than those observed in 1dltD-treated
animals (Figure 8).
DISCUSSION
Research from the last decade investigating the immunobiotic
effector molecules has demonstrated that each individual
immunobiotic strain has a characteristic set of molecules, which
are responsible of its interaction with the host’s immune receptors
(28–30). Surface molecules of immunobiotic microorganisms,
including exopolysaccharides, cell wall peptidoglycan, and LTA,
have been frequently associated with their immunomodulatory
effects (28, 29, 31, 32). In this regard, several reports have
emphasized the importance of LTA in the immunomodulatory
properties of some probiotic lactobacilli.
A 1dltD mutant from L. plantarum WCFS1, affected in the
LTA biosynthesis pathway, was found to incorporate much less
D-Ala in its LTA than the WT strain (33). The D-Ala content
defect in the LTA significantly altered the immunomodulatory
ability of the 1dltD mutant from WCFS1 strain. The mutant
showed a higher anti-inflammatory activity when compared to
the parental strain in both in vitro and in vivo studies. The
1dltD mutant from L. plantarum WCFS1 was more efficient
than the WT strain to improve IL-10 production and reduce
TNF-α, IL-12, and IFN-γ in human PBMCs and monocytes.
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FIGURE 7 | Effect of a D-alanyl-lipoteichoic acid biosynthesis protein (dltD) mutant from Lactobacillus plantarum CRL1506 on the innate antiviral immune response
triggered by Toll-like receptor 3 (TLR3) activation in mice intestine. Levels of serum interferon (IFN)-β, IFN-γ, interleukin (IL)-10, tumor necrosis factor (TNF)-α, IL-6,
and IL-15 in mice orally treated with wild-type (WT) or 1dltD mutant from Lactobacillus rhamnosus CRL1506 and challenged with an intraperitoneal injection of the
viral molecular associated pattern poly(I:C). Mice with no lactobacilli treatment and challenged with poly(I:C) were used as controls. The results represent data from
three independent experiments. Significant differences when compared to the control group: *P < 0.05.
In addition, the treatment of mice with the 1dltD mutant
from L. plantarum WCFS1 significantly reduced the percentage
of mice displaying diarrhea after trinitrobenzene sulfonic acid
(TNBS) administration when compared with animals receiving
the L. plantarum WT strain (33). Other reports provided similar
results for L. acidophilus NCFM (27) and L. rhamnosus GG
(34) in which LTA mutant strains improved the production
of anti-inflammatory cytokines in immune cells and reduced
the severity of dextran sulfate sodium (DSS)-induced colitis in
mice. Those results indicated that LTA from some lactobacilli
strains have immune stimulatory effects. In line with this
assumption, it was demonstrated that LTA from L. fermentum
YIT0159 and L. casei YIT9029 induces TNF-α expression in
macrophages (35).
In contrast to the pro-inflammatory properties of lactobacilli
LTA, others works reported that those molecules have anti-
inflammatory activities in some Lactobacillus strains. The LTA
from L. plantarum K8 was a weaker inducer of nitric oxide
(NO) and TNF-α in macrophages when compared with the
LTA from Bacillus subtilis or Staphylococcus aureus (36). The
LTA from the K8 strain was able to act as an antagonist
in the induction of TNF-α by monocytes challenged with
lipopolysaccharide (LPS) (37), peptidoglycan of Shigella flexneri
(38), or LTA from S. aureus (39). Moreover, the purified LTA
from L. plantarum K8 differentially modulated the response
of human keratinocytes to the stimulation with TNF-α or
IFN-γ (40). LTA-treated keratinocytes had a significantly
reduced activation of TNF-α/p65/p38 and IFN-γ/STAT1/2/JAK2
pathways with a subsequent reduced expression of inflammatory
factors such as the complement protein C3. It was also
described that the LTA from L. plantarum K8 had the
ability to regulate the TLR2-triggered inflammatory response
in intestinal epithelial cells (IECs). Caco-2 cells treated with
L. plantarum K8 LTA and then challenged with the TLR2
agonist Pam2CSK4 showed significantly lower expression of IL-
8 when compared to control cells (41). In vivo studies also
support the anti-inflammatory activities of LTA from lactobacilli.
L. casei BL23 had been shown to exert beneficial effects in
the DSS-induced murine model of ulcerative colitis, and it was
reported that the 1dltD mutant from the BL23 strain was
unable to protect against the inflammatory damage induced
by DSS (42).
These contrasting results could be explained by the chemical
and structural differences of LTA molecules. Chemical and
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FIGURE 8 | Effect of a D-alanyl-lipoteichoic acid biosynthesis protein (dltD) mutant from Lactobacillus plantarum CRL1506 on the innate antiviral immune response
triggered by Toll-like receptor 3 (TLR3) activation in mice intestine. Numbers of CD3+NK1.1+ and CD3+CD8αα+ intraepithelial lymphocytes (IELs), expression of
NKG2D on IELs, and expression of intestinal RAE1 gene in mice orally treated with wild-type (WT) or 1dltD mutant from Lactobacillus rhamnosus CRL1506 and
challenged with an intraperitoneal injection of the viral molecular associated pattern poly(I:C). Mice with no lactobacilli treatment and challenged with poly(I:C) were
used as controls. The results represent data from three independent experiments. Significant differences when compared to the control group: *P < 0.05,
**P < 0.01. Significant differences when compared to the indicated group: †P < 0.05.
molecular studies of LTA highlighted the variety in their structure
by means of the number of acyl chains and the degree of
saturation in the lipid chain as well as the D-ala or sugars
substitutions on the Gro-P chains (43) that could explain their
differential immunomodulatory effects. In addition, it should
be considered that the immunomodulatory activities of LTA
derived from lactobacilli have been studied in different contexts
of cytokine- or bacteria-induced inflammatory responses, adding
additional complexity to the interpretations. Of note, the
potential beneficial effect of LTA from lactobacilli in the context
of viral infection or viral pattern recognition receptors-mediated
inflammation has not been explored in depth.
In an interesting study performed by Kim et al. (44), it
was demonstrated that the LTA isolated from L. plantarum K8
was able to regulate mitogen-activated protein kinase (MAPK)
phosphorylation and nuclear factor (NF)-κB activation and
reduce IL-8 production in IPEC-J2 cells in response to the
challenge with the TLR3 agonist poly(I:C). The work also
demonstrated that LTA isolated from other lactobacilli strains
including L. delbrueckii, L. sakei, and L. rhamnosus GG did
not have the ability to differentially modulate IL-8 secretion
in poly(I:C)-challenged IECs. Moreover, comparative studies
evaluating the immunomodulatory potential of naive LTA and
dealanylated LTA from L. plantarum K8 clearly showed that
the dealanylated LTA failed to inhibit IL-8 secretion in IECs
after the activation of TLR3. In line with these previous results,
we demonstrated in this work that the LTA is involved in
the ability of the immunobiotic strain L. plantarum CRL1506
to reduce the expression of pro-inflammatory factors in IECs
challenged with poly(I:C). Previously, we demonstrated that PIE
cells are able to upregulate the expression of several inflammatory
factors including TNF-α, IL-6 (9, 10), IL-1β, IL-15, and the
chemokines CCL4, CXCL2, CXCL5, CCL8, CXCL10, and CCL5
(9) in response to poly(I:C) challenge. We also reported that
PIE cells treated with L. plantarum CRL1506 prior to TLR3
activation had a reduced expression of inflammatory cytokines
and chemokines (9, 10). Here, by using the expression of IL-
6 and CCL2 as markers of inflammation, we demonstrated
that the alteration in the incorporation of D-ala in the LTA
molecule of L. plantarum CRL1506 significantly diminished the
ability of the immunobiotic strain to modulate inflammatory
factor expression.
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Moreover, this work is the first in demonstrating in an
in vivo model the role of LTA from an immunobiotic
strain in the beneficial modulation of the intestinal innate
antiviral immune response triggered by TLR3 activation. We
demonstrated previously that L. plantarum CRL1506 reduced the
TLR3-induced small intestinal injury in mice by regulating the
production of pro-inflammatory cytokines and the interaction
of IECs with IELs (11) (Figure 9). Cell–cell interaction between
IECs and IELs is essential as a first line of defense against
viruses (45–47). In the context of viral infection, the cell death
program of IECs is regulated by their upregulation in the
expression of IL-15, which is a cytokine capable of stimulating
the activation of CD3+NK1.1+ IELs and inducing perforin-
mediated killing of virus-infected epithelial cells (46). The
activation of TLR3 in the intestinal tract of mice enhances
the expression of RAE1 in IECs, allowing their destruction
by interacting with NKG2D expressed on CD3+NK1.1+ IELs
(48). This mechanism of small intestinal injury that induces
villous atrophy and mucosal erosion (49) is particularly
relevant for rotavirus infection since it was reported that
treatment of mice with poly(I:C) or purified dsRNA from
rotavirus increased intestinal injury in a CD8αα+NKG2D+-
and RAE1-dependent manner (48, 49). In fact, blockade of
RAE1-NKG2D interaction avoids the cytotoxic effect of IELs
on IECs and prevents acute small intestinal injury in mice
challenged with rotavirus genomic dsRNA (48). Of interest, the
oral administration of L. plantarum CRL1506 to mice prior
the intraperitoneal challenge with poly(I:C) significantly reduced
the inflammatory-mediated intestinal tissue damage through the
downregulation of TNF-α, IL-1β, and IL-8, particularly IL-15
and RAE1, and the reduction of the numbers and activation
(NKG2D+ expression) of CD3+NK1.1+CD8αα+ cells (11).
Here, we observed that L. plantarum1dltD had a reduced
capacity for the protection of mice against the TLR3-mediated
inflammatory damage as demonstrated by the analysis of body
weight loss and serum markers of damage. Moreover, we
observed that the 1dltD mutant from L. plantarum CRL1506
was inefficient for reducing the expression of IL-15 and RAE1
in IECs or the expression of NKG2D in IELs (Figure 9),
indicating that the LTA from this immunobiotic strain is
the main molecule involved in their ability to regulate IL-
15/RAE1/NKG2D death pathway.
It was reported that the expression of NKG2D ligands such as
RAE1 on IECs is strongly modulated by the intestinal microbiota.
FIGURE 9 | Role of lipoteichoic acid in the beneficial effects Lactobacillus plantarum CRL1506 on the innate antiviral immune response triggered by Toll-like receptor
3 (TLR3) activation in the intestine.
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Studies in germ-free mice and ampicillin-treated mice lacking
gut commensal microbiota demonstrated that the absence of
microbial stimuli significantly upregulates the expression of
NKG2D ligands in IECs (50). Then, taking into consideration
the results of this work, it is tempting to speculate that LTA
would be at least one of the molecules used by the gut
microbiota to regulate the innate antiviral immune response
in the intestinal tract. In support of this assumption, it was
shown that gut commensal bacteria help in the establishment of
a regulatory milieu in the intestinal mucosa by increasing the
expression of IL-10 and TGF-β, which diminish the expression
of NKG2D ligands on the surface of IECs (51, 52). Of note,
L. plantarum CRL1506 is able to improve the intestinal levels
of IL-10 in poly(I:C)-challenged mice, while the 1dltD mutant
from CRL1506 strain was inefficient for inducing this effect.
The molecular mechanisms and specific importance of LTA
from microbiota and immunobiotic strains in the protection
against viral inflammatory-mediated intestinal damage require
further research.
Interestingly, although the L. plantarum CRL1506 1dltD
was less efficient in regulating the TLR3-mediated inflammatory
response in both in vitro and in vivo experiments, the mutant
strain was as efficient as the WT to improve the levels of IFN-
β in the intestine. It was reported that the LTA of probiotic
bacteria mediates its immunomodulatory activities in a TLR2-
dependent manner (33, 37, 39). Our previous studies evaluating
the interaction of L. plantarum CRL1506 with IECs demonstrated
that TLR2 is involved in the ability of the strain to differentially
modulate cytokines in response to TLR3 activation (10). The
use of anti-TLR2 Abs inhibited the ability of the CRL1506
strain to modulate TNF-α and IL-6 transcripts in PIE cells.
However, when blocking anti-TLR2 Abs were used to evaluate
the influence of L. plantarum CRL1506 on the production of
IFN-β in PIE cells, it was evident that this receptor was not
involved in the modulation of this antiviral factor (10). Those
previous findings and the results presented here indicate that
TLR2 should be linked to the effect of biologically active LTA
on IECs, but that other host receptors and microbial molecules
might also be involved in L. plantarum CRL1506 recognition
by the intestinal epithelium, and in its beneficial influence on
intestinal innate antiviral immune response. In addition, our
results demonstrated that L. plantarum CRL1506 1dltD was
as effective as the WT to reduce the serum levels of AST
and TNF-α and improve serum IFN-γ in poly(I:C)-challenged
mice. It have been proposed that the systemic effects of orally
administered probiotics are mediated mainly by the interaction
of these beneficial microbes with innate immune cells such
as macrophages. In the analyses of the profiles of cytokines
induced by probiotic lactobacilli, it was observed that changes
in serum cytokines reflected their production by intestinal and
peritoneal macrophages (53, 54). Therefore, it is tempting to
speculate that both 1dltD and WT strains from L. plantarum
CRL1506 would have the same capacity to modulate macrophage
activity and that the TRL2-LTA interaction would not be involved
in such modulation. More detailed experiments evaluating the
interaction of both 1dltD and WT strains with macrophages
would be of great importance to improve our understanding
of the role of LTA in the immunomodulatory activity of
L. plantarum CRL1506.
In conclusion, although further studies are needed to
elucidate all the active bacterial components responsible for the
immunomodulatory capacities of L. plantarum CRL1506, the
results of this work indicate that LTA is an important molecule
involved in the immunobiotic effects induced by this strain in the
intestinal innate antiviral immune response triggered by TLR3
activation. In line with previous studies (27, 33, 34), our results
also indicate that the use of immunobiotic mutants carrying
directed mutations could help to improve the understanding
of the molecular interactions of immunobiotics with the
host immune system and how that interaction beneficially
modulates the innate antiviral immune response. This study
is an important step toward insights in the mode of action
of immunobiotics and their influence in the protection against
viral-mediated inflammation.
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